|The landscape of somatic copy-number alteration across human cancers|
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
|Integrative clinical genomics of advanced prostate cancer|
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
|The molecular taxonomy of primary prostate cancer|
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
|Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth|
RB Montgomery, EA Mostaghel, R Vessella, DL Hess, TF Kalhorn, ...
Cancer research 68 (11), 4447-4454, 2008
|Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer|
Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ...
Cell 138 (2), 245-256, 2009
|Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B|
Y Sun, J Campisi, C Higano, TM Beer, P Porter, I Coleman, L True, ...
Nature medicine 18 (9), 1359-1368, 2012
|Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer|
EA Mostaghel, ST Page, DW Lin, L Fazli, IM Coleman, LD True, ...
Cancer research 67 (10), 5033-5041, 2007
|Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2|
B Lin, C Ferguson, JT White, S Wang, R Vessella, LD True, L Hood, ...
Cancer research 59 (17), 4180-4184, 1999
|Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy …|
WU Shipley, KA Winter, DS Kaufman, WR Lee, NM Heney, WR Tester, ...
Journal of Clinical Oncology 16 (11), 3576-3583, 1998
|Expression profiling reveals hepsin overexpression in prostate cancer|
JA Magee, T Araki, S Patil, T Ehrig, L True, PA Humphrey, WJ Catalona, ...
Cancer research 61 (15), 5692-5696, 2001
|Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer|
A Kumar, I Coleman, C Morrissey, X Zhang, LD True, R Gulati, R Etzioni, ...
Nature medicine 22 (4), 369-378, 2016
|Human cancers express a mutator phenotype|
JH Bielas, KR Loeb, BP Rubin, LD True, LA Loeb
Proceedings of the National Academy of Sciences 103 (48), 18238-18242, 2006
|Multicolor quantum dots for molecular diagnostics of cancer|
AM Smith, S Dave, S Nie, L True, X Gao
Expert review of molecular diagnostics 6 (2), 231-244, 2006
|Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease|
D Di Vizio, J Kim, MH Hager, M Morello, W Yang, CJ Lafargue, LD True, ...
Cancer research 69 (13), 5601-5609, 2009
|A causal role for ERG in neoplastic transformation of prostate epithelium|
O Klezovitch, M Risk, I Coleman, JM Lucas, M Null, LD True, PS Nelson, ...
Proceedings of the National Academy of Sciences 105 (6), 2105-2110, 2008
|Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors|
HL Kenerson, LD Aicher, LD True, RS Yeung
Cancer research 62 (20), 5645-5650, 2002
|Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors|
SN Agoff, LW Lamps, AT Philip, MB Amin, RA Schmidt, LD True, AL Folpe
Modern Pathology 13 (3), 238-242, 2000
|Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.|
W Tester, R Caplan, J Heaney, P Venner, R Whittington, R Byhardt, ...
Journal of clinical oncology 14 (1), 119-126, 1996
|Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone|
MP Roudier, LD True, CS Higano, H Vesselle, W Ellis, P Lange, ...
Human pathology 34 (7), 646-653, 2003
|A molecular correlate to the Gleason grading system for prostate adenocarcinoma|
L True, I Coleman, S Hawley, CY Huang, D Gifford, R Coleman, TM Beer, ...
Proceedings of the National Academy of Sciences 103 (29), 10991-10996, 2006